Cargando…

Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer

BACKGROUND: Receptor tyrosine kinases promote tumor progression in many cancers, although oncologic activation differs between diffuse-type gastric cancer (DGC) and intestinal-type gastric cancer (IGC). Fibroblast growth factor receptor (FGFR) is one RTK, and we previously reported the clinical sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inokuchi, Mikito, Murase, Hideaki, Otsuki, Sho, Kawano, Tatsuyuki, Kojima, Kazuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217622/ https://www.ncbi.nlm.nih.gov/pubmed/28056982 http://dx.doi.org/10.1186/s12957-016-1081-4

Ejemplares similares

TPX2 expression is associated with poor survival in gastric cancer
por: Tomii, Chiharu, et al.
Publicado: (2017)

High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival
por: Nasri, Baongoc, et al.
Publicado: (2017)

Postoperative Complications of Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Gastric Cancer in a Meta-Analysis of High-Quality Case-Controlled Studies
por: Inokuchi, Mikito, et al.
Publicado: (2016)

Impact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer
por: Inokuchi, Mikito, et al.
Publicado: (2014)

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
por: Inokuchi, Mikito, et al.
Publicado: (2015)

Clinical significance of platelet derived growth factor-C and -D in gastric cancer
por: OGAWA, NORIHITO, et al.
Publicado: (2015)

EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013)

Prognostic value of RKIP and p-ERK in gastric cancer
por: Fujimori, Yoshitaka, et al.
Publicado: (2012)

A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
por: Fukamachi, Hiroshi, et al.
Publicado: (2019)

FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort
por: Schrumpf, Thorben, et al.
Publicado: (2022)

Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
por: Nishikawaji, Taketo, et al.
Publicado: (2016)

Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer
por: Tanabe, Shihori, et al.
Publicado: (2020)

Serum gastrin levels in patients with intestinal and diffuse type of gastric cancer.
por: Rakic, S., et al.
Publicado: (1991)

Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
por: Pavlovic, Mladen, et al.
Publicado: (2018)

Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer
por: Díaz del Arco, Cristina, et al.
Publicado: (2022)

Adhesion of Gastric Cancer Cells to the Enteric Nervous System: Comparison between the Intestinal Type and Diffuse Type of Gastric Cancer
por: Girot, Paul, et al.
Publicado: (2022)

Feasibility of laparoscopic total gastrectomy in overweight patients: Implications of less impact of overweight on laparoscopic versus open approach
por: Nakagawa, Masatoshi, et al.
Publicado: (2018)

Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951.
por: Lundegårdh, G., et al.
Publicado: (1991)

Low SP1 Expression Differentially Affects Intestinal-Type Compared with Diffuse-Type Gastric Adenocarcinoma
por: Lee, Hun Seok, et al.
Publicado: (2013)

Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer
por: Shi, Wenhao, et al.
Publicado: (2023)

Prognostic Significance of Tumour Budding and Desmoplastic Reaction in Intestinal-Type Gastric Adenocarcinoma
por: Pun, Cherry, et al.
Publicado: (2022)

Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer
por: Kim, Seo Ree, et al.
Publicado: (2020)

Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer
por: Tanaka, Hiroaki, et al.
Publicado: (2021)

Do Differences in Levels, Types, and Duration of Muscle Contraction Have an Effect on the Degree of Post-exercise Depression?
por: Miyaguchi, Shota, et al.
Publicado: (2016)

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Evolutionary History of the Risk of SNPs for Diffuse-Type Gastric Cancer in the Japanese Population
por: Iwasaki, Risa L., et al.
Publicado: (2020)

Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma
por: Hu, Mengdie, et al.
Publicado: (2022)

Cell Cycle Regulation and DNA Damage Response Networks in Diffuse- and Intestinal-Type Gastric Cancer
por: Tanabe, Shihori, et al.
Publicado: (2021)

Relation between outcomes and localisation of p-mTOR expression in gastric cancer
por: Murayama, T, et al.
Publicado: (2009)

Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer
por: Perrot-Applanat, Martine, et al.
Publicado: (2019)

Biological Significance and Targeting of the FGFR Axis in Cancer
por: Chioni, Athina-Myrto, et al.
Publicado: (2021)

Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer
por: Inokuchi, M, et al.
Publicado: (2006)

The diffuse-type gastric cancer epidemiology enigma
por: Assumpção, Paulo Pimentel, et al.
Publicado: (2020)

A case of conservatively managed gastric perforation at a recurrent hiatal hernia site after laparoscopic paraesophageal repair
por: Ogo, Taichi, et al.
Publicado: (2023)

Comparison of survival between diffuse type and intestinal type early-onset gastric cancer patients: A large population-based study
por: Wang, Qiang, et al.
Publicado: (2023)

Increased Expression of Sucrase and Intestinal‐type Alkaline Phosphatase in Human Gastric Carcinomas with Progression
por: Nakamura, Wataru, et al.
Publicado: (1998)

Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1(amp)-FGFR2(norm)-FGFR2-IIIc(high) Axis in Diffuse Gastric Cancer
por: Teles, Sara Pinto, et al.
Publicado: (2019)

Rapid Development of Intestinal Type Gastric Adenocarcinoma
por: Oh, Young S., et al.
Publicado: (2011)

In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients
por: Kuboki, Yasutoshi, et al.
Publicado: (2017)

Chronic atrophic gastritis and intestinal metaplasia surrounding diffuse-type gastric cancer: Are they just bystanders in the process of carcinogenesis?
por: Shin, Seung Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lnio5i38ar3eoph8n0pskfkc18